Join Transform 2021 for the most important themes in enterprise AI & Data. Learn more.

Theranos, a maker of devices that monitor drug reactions, has raised $45 million of an expected $100 million, according to a filing with the SEC. Started by former Stanford undergrad Elizabeth Holmes at the age of 19, the company is backed by Draper Fisher Jurvetson, ATA Ventures, Tako Ventures and Continental Properties Inc. Theranos develops real-time monitoring systems that enable patients and their doctors to make more informed medical decisions. The handheld devices wirelessly monitor a patient’s blood.

Theranos, which is based in Palo Alto, Calif. and was founded in 2003, has raised more than $70 million in funding to date.


VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform
  • networking features, and more
Become a member